Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression Carmen Peña-BautistaLourdes Álvarez-SánchezConsuelo Cháfer-Pericás Original Communication 28 July 2023 Pages: 4585 - 4592
Pediatric de novo movement disorders and ataxia in the context of SARS-CoV-2 Nina-Maria WilpertAna Luísa de Almeida MarcelinoMarc Nikolaus Review Open access 29 July 2023 Pages: 4593 - 4607
Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study Wei ZhuYangjing BaiYan Jiang Original Communication 30 July 2023 Pages: 4608 - 4616
Central nervous system complications in SARS-CoV-2-infected patients Zhonggui LiDanyu LinEnxiang Tao Original Communication Open access 13 August 2023 Pages: 4617 - 4631
Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies Ronen SpiererIdit LaviDaniel Golan Original Communication 17 August 2023 Pages: 4632 - 4639
Characterizing long-COVID brain fog: a retrospective cohort study Grace Y. LamRonald W. DamantMaeve P. Smith Original Communication 09 August 2023 Pages: 4640 - 4646
A hypoarousal model of neurological post-COVID syndrome: the relation between mental fatigue, the level of central nervous activation and cognitive processing speed Eva Maria MartinSven RupprechtKathrin Finke Original Communication Open access 25 June 2023 Pages: 4647 - 4660
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19 Emilie N. LiuJennifer H. YangJennifer S. Graves Original Communication 26 July 2023 Pages: 4661 - 4672
Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients Ameli GerhardVanessa RaederChristiana Franke Short Commentary Open access 29 July 2023 Pages: 4673 - 4677
Association between vaccination and the risk of central demyelination: results from a case-referent study Lamiae Grimaldi-BensoudaCaroline PapeixLucien Abenhaim Original Communication Open access 23 June 2023 Pages: 4678 - 4686
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study Maria Pia AmatoRoberto BergamaschiMaria Trojano Original Communication Open access 05 July 2023 Pages: 4687 - 4696
Functional connectivity modifications in monoaminergic circuits occur in fatigued MS patients treated with fampridine and amantadine Maria A. RoccaPaola ValsasinaMassimo Filippi Original Communication 18 July 2023 Pages: 4697 - 4706
Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy Shemonti HasanOnilia ZorioCristina Valencia-Sanchez Letter to the Editors 19 August 2023 Pages: 4707 - 4712
Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis Hongyuan ChuXinyu ZhangXu Yang Review Open access 28 June 2023 Pages: 4713 - 4728
The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis Qiaochu ZhuDandan XuYan Zhao Review Open access 28 June 2023 Pages: 4729 - 4743
Determining ICU EEG periodic patterns and why it matters Philippe GélisseWilliam O. TatumPeter W. Kaplan Review Open access 01 July 2023 Pages: 4744 - 4752
Serum levels of neurofilament light chains in pediatric multiple sclerosis: a systematic review and meta-analysis Alexandru-Ştefan NiculaeLucia-Elena NiculaeVitalie Văcăraş Review 02 July 2023 Pages: 4753 - 4762
Diagnosis and management of Becker muscular dystrophy: the French guidelines Armelle MagotKarim WahbiThe French BMD working group Review 09 July 2023 Pages: 4763 - 4781
Efficacy and safety of noninvasive brain stimulation for patients with cerebellar ataxia: a systematic review and meta-analysis of randomized controlled trials Cheng GongYi LongYun Luo Review 17 July 2023 Pages: 4782 - 4799
Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis Igal RosensteinMarkus AxelssonJan Lycke Original Communication Open access 14 June 2023 Pages: 4800 - 4811
Fatigue in stroke survivors: a 5-year follow-up of the Fall study of Gothenburg Lior SchnitzerPer-Olof HanssonCarina U. Persson Original Communication Open access 15 June 2023 Pages: 4812 - 4819
Frailty in aneurysmal subarachnoid hemorrhage: the risk analysis index Alis J. DicpinigaitisSyed Faraz KazimChristian A. Bowers Original Communication 17 June 2023 Pages: 4820 - 4826
Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy Roberto GasparottiAlessandro SalvalaggioChiara Briani Original Communication Open access 17 June 2023 Pages: 4827 - 4840
Brain FDG-PET correlates of saccadic disorders in early PSP G. PinJ. LabouréL. Koric Original Communication 18 June 2023 Pages: 4841 - 4850
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial Chloé LaurencinNoémie TimestitStéphane Thobois Original Communication Open access 20 June 2023 Pages: 4851 - 4859
Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis: a retrospective study Yingfang LiangGangqi WangHao Zeng Original Communication Open access 20 June 2023 Pages: 4860 - 4867
The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach Giammarco MilellaStefano ZoccolellaGiancarlo Logroscino Original Communication 20 June 2023 Pages: 4868 - 4875
Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis Penelope TilsleyIsanbert Arun StrohmeyerJan-Patrick Stellmann Original Communication 21 June 2023 Pages: 4876 - 4888
Correction to: Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis Penelope TilsleyIsanbert Arun StrohmeyerJan-Patrick Stellmann Correction 26 July 2023 Pages: 4889 - 4889
Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis Jakob I. DoerrfussJonas M. HebelMartin Holtkamp Original Communication Open access 21 June 2023 Pages: 4890 - 4902
Establishing normative data for the evaluation of cognitive performance in Huntington’s disease considering the impact of gender, age, language, and education Alžbeta MühlbäckJosef Manathe REGISTRY investigators of the European Huntington’s Disease Network, the Enroll-HD investigators Original Communication Open access 22 June 2023 Pages: 4903 - 4913
Risk characteristics of alcohol and/or drug misuse in repeat emergency department attendees for seizures: a case–control study Sarah LennardWilliam HenleyRohit Shankar Original Communication 24 June 2023 Pages: 4914 - 4921
Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany Felix HeinrichIsabell CordtsOlivia Schreiber-Katz Original Communication Open access 25 June 2023 Pages: 4922 - 4938
Brain MRI correlations with disease burden and biomarkers in Fabry disease Yawen ZhaoYing ZhuYining Huang Original Communication Open access 25 June 2023 Pages: 4939 - 4948
Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals Ludmila KucikovaJianmin ZengLi Su Original Communication Open access 26 June 2023 Pages: 4949 - 4958
The genetic and clinical spectrum in a cohort of 39 families with complex inherited peripheral neuropathies Mengli WangHonglan YangRuxu Zhang Original Communication 26 June 2023 Pages: 4959 - 4967
Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study Raffaele DubbiosoVincenzo ProviteraMaria Nolano Original Communication Open access 26 June 2023 Pages: 4968 - 4977
Synergistic effects of vagus nerve stimulation and antiseizure medication Yaroslav WinterKatharina SandnerSergiu Groppa Original Communication Open access 27 June 2023 Pages: 4978 - 4984
A typology of cerebral small vessel disease based on imaging markers Christoph SperberArsany HakimRoza Umarova Original Communication Open access 27 June 2023 Pages: 4985 - 4994
The added value of spinal cord lesions to disability accrual in multiple sclerosis Serena RuggieriLuca ProsperiniCarlo Pozzilli Original Communication Open access 29 June 2023 Pages: 4995 - 5003
Study of the relationship between onset lateralization and hemispheric white matter asymmetry in Parkinson's disease Yuxia ZhuSichen LiLifen Chen Original Communication 29 June 2023 Pages: 5004 - 5016
Incidence and prevalence of Spinal and bulbar muscular atrophy in South Korea: a nationwide population-based study Jin-Mo ParkMinsung KangJin-Sung Park Original Communication 30 June 2023 Pages: 5017 - 5022
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Lisa NeumanAdrien Josephthe participants to the Prospective Multicenter MATRISK study Original Communication 01 July 2023 Pages: 5023 - 5033
Acute pediatric encephalitis: etiology, course, and outcome of a 12-year single-center immunocompetent cohort Giacomo BriscaChiara MariniMaria Margherita Mancardi Original Communication 03 July 2023 Pages: 5034 - 5047
Epilepsy associated with cerebral cavernous malformations managed with stereotactic radiosurgery: an international, multicenter study Chloe DumotGeorgios MantziarisJason P. Sheehan Original Communication 05 July 2023 Pages: 5048 - 5056
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A Annalaura TorellaIvana RiccaAlessandro Filla Original Communication Open access 07 July 2023 Pages: 5057 - 5063
Combined genotype of HCRTR2 and CLOCK variants in a large family of cluster headache with familial periodicity phenotype Cyprian Popescu Original Communication 07 July 2023 Pages: 5064 - 5070
The rising role of cognitive reserve and associated compensatory brain networks in spinocerebellar ataxia type 2 Libera SicilianoGiusy OlivitoMaria Leggio Original Communication Open access 08 July 2023 Pages: 5071 - 5084
Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report Rui WangDongren SunHongyu Zhou Letter to the Editors 19 May 2023 Pages: 5085 - 5089
Parkinson’s disease in a patient with olfactory hypoplasia: a model case of “body-first Lewy body disease” providing insights into the progression of α-synuclein accumulation Tomoyasu MatsubaraShigeo MurayamaYuko Saito Letter to the Editors 29 May 2023 Pages: 5090 - 5093
